0001562180-21-005810.txt : 20210903
0001562180-21-005810.hdr.sgml : 20210903
20210903161230
ACCESSION NUMBER: 0001562180-21-005810
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hordo Christian
CENTRAL INDEX KEY: 0001830070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 211236639
MAIL ADDRESS:
STREET 1: C/O SANA BIOTECHNOLOGY, INC.
STREET 2: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-09-01
false
0001770121
Sana Biotechnology, Inc.
SANA
0001830070
Hordo Christian
C/O SANA BIOTECHNOLOGY, INC.
188 EAST BLAINE STREET, SUITE 400
SEATTLE
WA
98102
false
true
false
false
EVP, Chief Business Officer
Common Stock
2021-09-01
4
M
false
1134.00
1.48
A
974934.00
D
Common Stock
2021-09-01
4
S
false
1134.00
25.0036
D
973800.00
D
Common Stock
2021-09-01
4
S
false
3002.00
25.0057
D
970798.00
D
Stock Option (Right to Buy)
1.48
2021-09-01
4
M
false
1134.00
0.00
D
2030-01-26
Common Stock
1134.00
135266.00
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive.
This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.
/s/ James J. MacDonald, Attorney-in-Fact for Christian Hordo
2021-09-03